Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy Academic Article uri icon

Overview

MeSH Major

  • Central Nervous System Neoplasms
  • Combined Modality Therapy
  • Lymphoma, Non-Hodgkin
  • Methotrexate

abstract

  • Consolidation treatment with WBRT, HDAC, or both does not appear to improve survival in patients who achieved a CR with induction MTX-based therapy. Age, KPS, and risk of delayed neurotoxicity must be considered in the choice of consolidation regimens.

publication date

  • September 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.23670

PubMed ID

  • 18618509

Additional Document Info

start page

  • 1025

end page

  • 31

volume

  • 113

number

  • 5